Abstract:Sami A Alawfi Clinical Laboratory Sciences Department, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia Correspondence: Sami A Alawfi, Email Introduction: Candidiasis, commonly known as yeast infection, affects people worldwide due to the overgrowth of Candida species. Of several types, genital candidiasis, particularly vulvovaginal candidiasis (VVC), primarily caused by C. albicans is frequently observed in females of reproductive age. Candidiasis has also become a serious issue in the post-pandemic era, as it occurs as a secondary infection in COVID-19 patients during or after the course of viral illness. Therefore, this study investigated the incidence of C. albicans infections in women of reproductive age, and its relationship with the incidence of COVID-19 and vaccination in Saudi Arabia. Objective: Additionally, this study aimed to determine the awareness of women on candidiasis and its subsequent impact on the occurrence of infection. A survey-based quantitative study was conducted in which primary data were collected from participants using a self-reported questionnaire. Methods: A total of 200 women aged 18– 45 were selected through random sampling. Apart from their sociodemographic characteristics, the history of COVID-19 incidence, COVID-19 vaccination, and candidiasis occurrences among respondents were recorded. Their level of awareness and knowledge of candidiasis, along with their perceptions of strategies for mitigating the risk of incidence, were also evaluated. The collected data were analysed using different statistical tools. Results: The findings of this study revealed a positive correlation between candidiasis, viral infection, and vaccination, regardless of the type and dosage of vaccine administered. Furthermore, both COVID-19 incidence and vaccination had a positive and significant impact on the occurrence of candidiasis among Saudi women. Conclusion: Despite certain limitations, this study has theoretical and managerial implications for improved management of candidiasis in the post-COVID era. Keywords: awareness, candidiasis, COVID-19, COVID-19 vaccine, pandemic, incidence Over the past three decades, fungal pathogens have become major contributors to life-threatening illnesses and increased mortality in humans. 1 Candidiasis, also referred to as oidiomycosis, poses a significant medical challenge worldwide. 2 Candidiasis is the most prevalent opportunistic yeast infection and encompasses a spectrum of non-life-threatening mucocutaneous and life-threatening invasive diseases. 3 This fungal infection is attributed to yeast species of Candida genus, with C. albicans being the most prevalent compared to C. glabrata, C. tropicalis, C. parapsilosis and other non- C. albicans species. 4 These dimorphic yeasts, including C. albicans are commensal in nature and inhabit the skin and gastrointestinal, reproductive and urinary tracts. However, overgrowth of these species can lead to various superficial infections, classified based on the affected area: genital candidiasis (genital parts), mucosal candidiasis (mucous membranes), oropharyngeal candidiasis (mouth and throat), and cutaneous candidiasis (skin). 5 Although Candida species typically exist as commensals within the human host, they display virulence attributes when opportunities arise, particularly in individuals with compromised immune systems. 6 This allows them to enter the bloodstream (systemic candidiasis or candidemia) and invade vital organs (invasive candidiasis), leading to life-threatening systemic infections. A wide variety of causal factors contribute to yeast infections, including dietary factors, personal hygiene practices, impaired immune systems, and the prolonged use of broad-spectrum antibiotics or immunosuppressive drugs. This complexity highlights candidiasis as a prime example of multifactorial syndrome. 2 The mortality rate associated with invasive candidiasis is estimated to be between 19% and 40%, 7 and it significantly increases to approximately 70% among patients in intensive care units (ICUs), 8 contributing to approximately 1.5 million annual deaths and excess economic costs. 9 The recent emergence of multidrug-resistant strains is also responsible for this higher graph, as it significantly hampers the effectiveness of antifungal treatments. 10 Before the COVID-19 outbreak, Candida infections were a notable concern, with the highest prevalence reaching up to 9% in the most affected group, specifically, those aged 25–34 years. 11 The pandemic further exacerbated the i -Abstract Truncated-

Oral candidiasis and potential risk factors among disabled and non-disabled in Al-Baha region, Saudi Arabia

Oral Prevalence of Candida Species in Patients Undergoing Systemic Glucocorticoid Therapy and the Antifungal Sensitivity of the Isolates

Oral candidiasis in HIV-uninfected pediatric population in areas with limited fungal diagnosis: A case study from a tertiary hospital, Tanzania

Prevalence, molecular identification, and genotyping of Candida species recovered from oral cavity among patients with diabetes mellitus from Tehran, Iran

Investigation of Candidal Species among People Who Suffer from Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma

Oral Health Status, Oral Health Behaviors, and Oral Health Care Utilization among Persons with Disabilities in Saudi Arabia

The prevalence of oral Candida infections in periodontitis patients with type 2 diabetes mellitus

Etiology and risk factors analysis of oral candidiasis in patients with chronic obstructive pulmonary disease

Characterization of Oral Candidiasis and the Candida Species Profile in Patients with Oral Mucosal Diseases.

Prevalence of candida SSP in oral mucosa and dentures of institutionalized elderly

Prevalence of Oral Candidiasis among Children Caused by Different Candida Species

Oral Cavity and Candida albicans: Colonisation to the Development of Infection

Candida species and oral mycobiota of patients clinically diagnosed with oral thrush

Invasive Candidiasis in pediatric patients at King Fahad Medical City in Central Saudi Arabia

Accessibility of Patients With Special Healthcare Needs to Dental Care in the Eastern Province of Saudi Arabia: A Multicentre Study From Perspective of Caregiver and Dental Care Providers

Prevalence and Pattern of Oral and Maxillofacial Pathology in Al-Qassim Region, Saudi Arabia

Health of Saudi Women in the Post-Pandemic Era: Candidiasis Incidence and Post COVID-19 and COVID-19-Vaccination

Oropharyngeal Candida Colonization in Patients with Acute Myeloid Leukemia

Prevalence of oral Candida infection and associated factors in hospitalized patients at Hue University Medicine and Pharmacy Hospital

Evaluation of oral health-related quality of life and its association with mental health status of patients with type 2 diabetes mellitus in the post-COVID-19 pandemic era: A study from Central Saudi Arabia

Epidemiology of oral cancer in Arab countries